A shingles vaccine lowers the risk of a heart attack or stroke for up to eight years, according to new research. People given ...

Record HEPLISAV-B® first quarter net product revenue of $65 million, representing 36% year-over-year growth Top-line results in Part 1 of Phase 1/2 shingles vaccine ...

The shingles vaccine has benefits that stretch beyond protecting older adults from the painful skin condition, a new study ...

The possibility that it was shingles never crossed her mind. After all, she’d always heard it was an illness that mainly ...

Q1 2025 Earnings Call Transcript May 6, 2025 Dynavax Technologies Corporation misses on earnings expectations. Reported EPS is $0.01 EPS, expectations were $0.03. Operator: Good day ladies and ...

“Our study suggests that the shingles vaccine may help lower the risk of heart disease, even in people without known risk ...

The research looked at the data on shingles vaccination status from 2012 onwards and analysed it with cardiovascular health ...

Vaccination can help prevent shingles – a condition that an estimated one in three people in the U.S. will develop in their ...

A new analysis of existing literature in Annals of Internal Medicine suggests patients prescribed antivirals for nonsevere ...

A study in European Heart Journal yesterday shows a 23% lower risk of cardiovascular events in recipients of the shingles ...

Researches have found people given the shingles shot had a 23% lower risk of cardiovascular events for up to 8 years and ...